Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNTARA LIMITED Share Issue/Capital Change 2012

Aug 9, 2012

65830_rns_2012-08-09_70c7466e-b4cb-4997-bd7b-1e321e6ac737.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [144 x 21] intentionally omitted <==

==> picture [144 x 20] intentionally omitted <==

10 August 2012 Manager of Company Announcements Australian Stock Exchange Exchange Centre Level 3 20 Bridge Street Sydney NSW 2000

Dear Sir/Madam,

Proposed Issue of Securities to Non Executive Director

In accordance with Listing Rule 3.10.3, Pharmaxis advises that the directors have resolved to grant 30,000 zero grant and zero exercise price employee options under the Company’s employee option plan to Dr Simon Buckingham, in connection with his appointment as a Non Executive Director earlier this year.

The Board’s policy as set out in the Company’s annual Remuneration Report, is to grant newly appointed directors, subject to shareholder approval in each instance, equity in the Company. The grant requires shareholder approval which will be sought at the annual general meeting of the Company:

Class of security Unlisted zero grant and zero exercise price employee optionsover Pharmaxis Ltd ordinaryshares.
Number to be issued 30,000
Issueprice Nil
Exerciseprice Nil
Vesting Three years from the grant date subject to Dr Buckinghambeinga director of the Companyat this time.
Conditions applicable to theshares issued on exercise ofPerformance Rights While Dr Buckingham is a Director, the shares issued onexercise of options cannot be traded without prior approvalof the Board.
Shareholder approval Shareholder approval will be sought at the 2012 AnnualMeeting.
Purpose of issue To be issued to the non-executive director under, and inaccordance with the Pharmaxis employee option plan,followinghis appointment to the Board earlier in theyear.
Issue to class No

Further details will be included in the notice of meeting for the 2012 Annual General Meeting.

Pharmaxis Ltd Unit 2, 10 Rodborough Road T 02 9454 7200 ABN 75 082 811 630 Frenchs Forest NSW 2086 F 02 9451 3622 Australia www.pharmaxis.com.au

The Company will lodge the relevant Appendix 3B when required by the Listing Rules of Australian Securities Exchange.

Sincerely,

==> picture [157 x 77] intentionally omitted <==

David McGarvey Company Secretary